Released Jan 30, 2017, after the close
10-K filed Jan 31, 2017, 92 days after period end · 0001654954-17-000601
Q4 2016 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income-$513.32K-$513.32K derivedN/M vs Q4 2015N/M vs Q3 2016
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$1,074,791−47.5%
Operating Incomederived-$449,758N/M
Operating Cash Flowderived$463,239−60.5%
Free Cash Flowderived-$258,985N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$513.32K | $523.45K | $826.87K | $1.22M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pharma-Bio Serv, Inc. · CIK 1304161 · Engraved from SEC EDGAR